Celecoxib allergies and cross-reactivity [3]

Internal Medicine Journal

Volumn 36, Issue 11, 2006, Pages 754-755

  Ch'ng, A ^a   Lowe, M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BENDROFLUMETHIAZIDE; BUMETANIDE; CELECOXIB; CHLOROTHIAZIDE; CHLORTALIDONE; DAPSONE; FUROSEMIDE; GLICLAZIDE; GLIMEPIRIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; PROBENECID; SALAZOSULFAPYRIDINE; SULFACETAMIDE; SULFADIAZINE; SULFADOXINE; SULFAMETHOXAZOLE; TOLBUTAMIDE;

AGED; CASE REPORT; CLINICAL FEATURE; CROSS ALLERGY; CROSS REACTION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPOTENSION; LETTER; LUNG EDEMA; MACULOPAPULAR RASH; PRIORITY JOURNAL; RASH; URTICARIA;

AGED; ANALGESICS; ANTI-BACTERIAL AGENTS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; PYRAZOLES; SULFONAMIDES;

EID: 33749857736     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01184.x     Document Type: Letter

References (4)

1. Pfizer. Celebrex (Celecoxib) Product Information, TGA Approval Date 4 April 2006. Available from URL: http://www.mims.hcn.net.au
2. Knowles S, Shapiro L, Shear NH. Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy. Drug Saf 2001; 24: 239-47.
3. Patterson R, Bellow AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther 1999; 21: 2065-79.
4. Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003; 349: 1628-35.